Express Scripts (ESRX) Says Anthem (ANTM) Intends to Move its Business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/4/2026
- S&P 500, Dow hit record highs on strong AI-linked earnings, Mideast deal hopes
- Caterpillar stock jumps on strong earnings and revenue beat
- Optical component stocks rally on proposed U.S. ban on Chinese tech
- BofA says this memory stock could double. Here are 5 reasons why
- Merck shares rise on big Q2 earnings beat, adjusted FY outlook
- Nutanix to cut 5% of workforce, expects up to $43M in charges
- Palantir posts 93% revenue growth in Q2 2026, raises full-year outlook
- Grainger CFO resigns, interim replacement named
- Microsoft joins, Broadcom exits Goldman's top-stocks list
- Walmart dips after Oppenheimer downgrades shares on difficult short-term setup
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
Express Scripts (ESRX) PT Lowered to $59 at Evercore ISI
April 25, 2017 12:43 PM EDTEvercore ISI lowered its price target on Express Scripts (NASDAQ: ESRX) to $59.00 (from $68.50) while maintaining a In Line rating.
Analyst Ross Muken commented, "Given the size / scope of the questions outstanding regarding ESRXs business model, we see valuation as... More
Express Scripts (ESRX) PT Lowered to $52 at Morgan Stanley; Renewal Cycle Could Lead to Margin Pressures
April 25, 2017 9:36 AM EDTMorgan Stanley lowered its price target on Express Scripts (NASDAQ: ESRX) to $52.00 (from $71.00) while maintaining a Underweight rating, following news that Anthem intends move its PBM business from the company.
Analyst Ricky Goldwasser lowers estimates on the announcement, suggesting the competitive landscape could deteriorate,... More
Cantor Fitzgerald Maintains Neutral Rating and $165 PT on Anthem (ANTM); 'Steps to Improve PBM Leverage Should be Positive'
April 24, 2017 5:26 PM EDTCantor Fitzgerald maintains Neutral rating and $165 price target on Anthem (NYSE: ANTM) as the company's pharmacy benefit manager, Express Scripts (ESRX), announced that it is unlikely that Anthem will renew its contract which expires on December 31, 2019.
Analyst Steven Halper notes the company generated... More
Express Scripts (ESRX) to Resume Trading at 4:45 PM ET
April 24, 2017 4:13 PM EDTExpress Scripts (NASDAQ: ESRX) to Resume Trading at 4:45 PM ET
... MoreExpress Scripts (ESRX) Tops Q1 EPS by 1c; Raises Outlook
April 24, 2017 4:02 PM EDTExpress Scripts (NASDAQ: ESRX) reported Q1 EPS of $1.33, $0.01 better than the analyst estimate of $1.32. Revenue for the quarter came in at $24.66 billion versus the consensus estimate of $24.99 billion.
Adjusted claims of 351.7 million, down 1% See Table 1GAAP net income of $546.3 million, up... MoreExpress Scripts (ESRX) Halted, News Pending
April 24, 2017 4:00 PM EDTExpress Scripts (NASDAQ: ESRX) Halted, News Pending
... More